Skip to main content
SIU Annual Conference Main banner
 
Presentation Icons
Surgery Day
Surgery Day
Bench-to-Bedside
Bench-to-Bedside
SIU@U
SIU@U
    Session Type: B2B

    7th B2B Uro-Oncology: GU Cancers Triad Meeting - PROSTATE CANCER

    Friday, October 31, 2025
    14:40 - 16:20 GMT+0

    Bench-to-Bedside SIU@U

    This educational programme is supported by:
    B2B Presenting Sponsors: Daiichi-Sankyo | AstraZeneca, Johnson & Johnson
    B2B Contributing Sponsors: Bristol Myers Squibb, CG Oncology, Ferring Pharmaceuticals, Merck Sharp & Dohme LLC, Novartis AG

      Moderator(s)

    • Caroline Moore

      NIHR Research Professor & Head of Urology
      University College London, United Kingdom

    B2B Scientific Programme Committee: Peter Black, Canada / Caroline Moore, United Kingdom / Simon Tanguay, Canada

    Learning Objectives :

    At the end of this session, attendees should be able to:
    • Evaluate the benefits, risks, and limitations of various treatment options across the management continuum in prostate cancer, bladder cancer, and kidney cancer
    • Recognize the role of imaging and genetic markers in guiding treatment decision-making.
    • Analyze the efficacy and safety of emerging therapeutic approaches for the management of GU cancers based on current clinical data.
    • Recall strategies to identify, manage, and mitigate adverse events related to systemic treatment.
    • Discuss the importance of personalized medicine, based on treatment costs and patient preference, while minimizing toxicity and maximizing efficacy.

    Presentations:

    • 14:40 - 15:10 GMT+0
      Case-Based Panel Discussion: Focal Therapy in Localized Prostate Cancer – Assessing Different Energy Sources

      Panelist: Hashim U. Ahmed – Imperial College London

      Moderator: Caroline Moore – University College London

      Panelist: Rafael Sanchez-Salas – McGill University

      Panelist: Kara Watts – Montefiore Medical Center; Albert Einstein College of Medicine

      Panelist: Alistair Grey – UCLH

    • 15:10 GMT+0
      Robotic Prostatectomy Balloon Debate: The Data on X Approach Is Sufficient for Widespread Implementation

      Moderator: Rafael Sanchez-Salas – McGill University

    • 15:10 - 15:50 GMT+0
      Hood

      Debater: Alan McNeill – Scotland

    • 15:10 - 15:50 GMT+0
      NeuroSAFE

      Debater: Derya Tilki – Martini-Klinik Prostate Cancer Center

    • 15:10 - 15:50 GMT+0
      Retzius Sparing

      Debater: Silvia Secco – Niguarda Hospital

    • 15:10 - 15:50 GMT+0
      Single Port

      Debater: John W. Davis – MD Anderson Cancer Center

    • 15:50 - 16:05 GMT+0
      The Role of Metformin Plus ADT in mHSPC – a STAMPEDE Update

      Speaker: Nick James – University of London

    • 16:05 - 16:20 GMT+0
      Theranostics in Locally Advanced Prostate Cancer

      Speaker: Jan Philipp Radtke – Department of Urology, University Hospital Duesseldorf